Molecular Therapy - Table of Contents alert Volume 23 Issue 9

If you are unable to see the message below, click here to view.

Advertisement Together we can advance cell therapies worldwide. Pall delivers the expertise to help you realize efficient, effective development and commercialization of cell therapies. Benefit from industry-leading cell manufacturing technologies and services - from unique single-use bioreactor systems to innovative Solohill® microcarriers. More... Your vision. Our expertise. Their future.  TABLE OF CONTENTS Volume 23, Issue 9 (September 2015) In this issue Editorial In This Issue Research Highlights Commentaries Original Articles Also new AOP Advertisement Open for Submissions Molecular Therapy - Oncolytics is an online-only, open access journal, focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. Explore the benefits of submitting your next research article: http://bit.ly/1rmVcio Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Join the Editors of Molecular Therapy for a dinner and "meet and greet" at the ESGCT and FSGT Collaborative Congress We hope you will join us for a "meet and greet" at the ESGCT and FSGT Collaborative Congress on September 18th, from 6:30-8pm. Enjoy dinner in the main hall and learn more about publishing in and getting involved with the Molecular Therapy family of journals. Space is limited, so we appreciate your RSVPing to the event by September 15th.     Editorial Top Hemophilia Gene Therapy: Caught Between a Cure and an Immune Response Roland W. Herzog Mol Ther 2015 23: 1411-1412; 10.1038/mt.2015.135 Full Text In This Issue Top In This Issue Mol Ther 2015 23: 1414; 10.1038/mt.2015.136 Full Text Research Highlights Top Research Highlights Mol Ther 2015 23: 1415; 10.1038/mt.2015.137 Full Text Commentaries Top mRNA: Fulfilling the Promise of Gene Therapy Drew Weissman and Katalin Karikó Mol Ther 2015 23: 1416-1417; 10.1038/mt.2015.138 Full Text Self-Destruct Genetic Switch to Safeguard iPS Cells Zoltán Ivics Mol Ther 2015 23: 1417-1420; 10.1038/mt.2015.139 Full Text Hopx and the Cardiomyocyte Parentage Michael D Schneider, Andrew H Baker and Paul Riley Mol Ther 2015 23: 1420-1422; 10.1038/mt.2015.140 Full Text Original Articles Top Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia Eyal Banin, Elisha Gootwine, Alexey Obolensky, Raaya Ezra-Elia, Ayala Ejzenberg, Lina Zelinger, Hen Honig, Alexander Rosov, Esther Yamin, Dror Sharon, Edward Averbukh, William W Hauswirth and Ron Ofri Mol Ther 2015 23: 1423-1433; advance online publication, June 19, 2015; 10.1038/mt.2015.114 Abstract | Full Text ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice Kai Y Mak, Ruth Chin, Sharon C Cunningham, Miriam R Habib, Joseph Torresi, Alexandra F Sharland, Ian E Alexander, Peter W Angus and Chandana B Herath Mol Ther 2015 23: 1434-1443; advance online publication, May 25, 2015; 10.1038/mt.2015.92 Abstract | Full Text Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma Mariana Malvicini, Esteban Fiore, Valentina Ghiaccio, Flavia Piccioni, Miguel Rizzo, Lucila Olmedo Bonadeo, Mariana García, Marcelo Rodríguez, Juan Bayo, Estanislao Peixoto, Catalina Atorrasagasti, Laura Alaniz, Jorge Aquino, Pablo Matar and Guillermo Mazzolini Mol Ther 2015 23: 1444-1455; advance online publication, June 24, 2015; 10.1038/mt.2015.112 Abstract | Full Text Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large AnimalsMTOPEN Andreas Thess, Stefanie Grund, Barbara L Mui, Michael J Hope, Patrick Baumhof, Mariola Fotin-Mleczek and Thomas Schlake Mol Ther 2015 23: 1456-1464; advance online publication, June 8, 2015; 10.1038/mt.2015.103 Abstract | Full Text miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction Swaroopa Guda, Christian Brendel, Raffaele Renella, Peng Du, Daniel E Bauer, Matthew C Canver, Jennifer K Grenier, Andrew W Grimson, Sophia C Kamran, James Thornton, Helen de Boer, David E Root, Michael D Milsom, Stuart H Orkin, Richard I Gregory and David A Williams Mol Ther 2015 23: 1465-1474; advance online publication, June 17, 2015; 10.1038/mt.2015.113 Abstract | Full Text An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells Shigeki Yagyu, Valentina Hoyos, Francesca Del Bufalo and Malcolm K Brenner Mol Ther 2015 23: 1475-1485; advance online publication, May 29, 2015; 10.1038/mt.2015.100 Abstract | Full Text Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human BloodMTOPEN Galina S Zamay, Olga S Kolovskaya, Tatiana N Zamay, Yury E Glazyrin, Alexey V Krat, Olga Zubkova, Ekaterina Spivak, Mohammed Wehbe, Ana Gargaun, Darija Muharemagic, Mariia Komarova, Valentina Grigorieva, Andrey Savchenko, Andrey A Modestov, Maxim V Berezovski and Anna S Zamay Mol Ther 2015 23: 1486-1496; advance online publication, June 10, 2015; 10.1038/mt.2015.108 Abstract | Full Text Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers Valentina Hoyos, Francesca Del Bufalo, Shigeki Yagyu, Miki Ando, Gianpietro Dotti, Masataka Suzuki, Lisa Bouchier-Hayes, Ramon Alemany and Malcolm K Brenner Mol Ther 2015 23: 1497-1506; advance online publication, June 18, 2015; 10.1038/mt.2015.110 Abstract | Full Text A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination ImmunotherapyMTOPEN Julien Valton, Valérie Guyot, Alan Marechal, Jean-Marie Filhol, Alexandre Juillerat, Aymeric Duclert, Philippe Duchateau and Laurent Poirot Mol Ther 2015 23: 1507-1518; advance online publication, June 10, 2015; 10.1038/mt.2015.104 Abstract | Full Text Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy Jonas Doerr, Annika Böckenhoff, Benjamin Ewald, Julia Ladewig, Matthias Eckhardt, Volkmar Gieselmann, Ulrich Matzner, Oliver Brüstle and Philipp Koch Mol Ther 2015 23: 1519-1531; advance online publication, June 10, 2015; 10.1038/mt.2015.106 Abstract | Full Text Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer Se Hoon Park, Caroline J Breitbach, Jeeyun Lee, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Anne Moon, Jae-Hee Mun, Erica M Sommermann, Liliana Maruri Avidal, Rick Patt, Adina Pelusio, James Burke, Tae-Ho Hwang, David Kirn and Young Suk Park Mol Ther 2015 23: 1532-1540; advance online publication, June 15, 2015; 10.1038/mt.2015.109 Abstract | Full Text Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor Joost H van den Berg, Raquel Gomez-Eerland, Bart van de Wiel, Lenie Hulshoff, Daan van den Broek, Adriaan Bins, Hanno L Tan, Jane V Harper, Namir J Hassan, Bent K Jakobsen, Annelies Jorritsma, Christian U Blank, Ton N M Schumacher and John B A G Haanen Mol Ther 2015 23: 1541-1550; advance online publication, April 21, 2015; 10.1038/mt.2015.60 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.